|
|
||||||||
Eur J Cardiothorac Surg 2006;29:983-985
© 2006 Elsevier Science NL
Division of Cardio-thoracic and Vascular Surgery, Department of Surgery, Oulu University Hospital, P.O. Box 21, 90029 Oulu, Finland
Received 8 December 2005; received in revised form 25 January 2006; accepted 9 February 2006.
* Corresponding author. Tel.: +358 8 315 2813/40 733973; fax: +358 8 315 2577. (Email: faustobiancari{at}yahoo.it).
Background: Increased levels of C-reactive protein (CRP) are associated with the presence and severity of atherosclerosis, and with increased risk of coronary events as well as of cardiac events after coronary percutaneous intervention. Methods: We have investigated whether preoperative CRP had an impact on the long-term outcome of 843 patients who underwent on-pump coronary artery bypass surgery (CABG). Results: Among operative survivors, patients with preoperative CRP <1.0 mg/dL had significantly better 12-year overall survival rate (74.1% vs 63.0%, p
= 0.004) and survival freedom from fatal cardiac event (86.7% vs 78.1%). Multivariate analysis including patients age, extracardiac arteriopathy, urgent/emergent operation, recent myocardial infarction, congestive heart failure, left ventricular ejection fraction, atrial fibrillation, transient ischemic attack/stroke, number of distal anastomoses, diabetes, and preoperative CRP
1.0 mg/dL or <1.0 mg/dL, showed that the latter was an independent predictor of late all-cause mortality (p
= 0.017, RR 1.60, 95% CI 1.092.35). Its impact on overall survival was particularly evident in patients with left ventricular ejection fraction <50% (CRP < 1.0 mg/dL: 58.7% vs CRP
1.0 mg/dL: 43.7%, p
< 0.00001). Conclusions: Increased preoperative levels of CRP are associated with significantly decreased overall survival after primary on-pump CABG.
Key Words: Coronary artery bypass surgery C-reactive protein Survival
This article has been cited by other articles:
![]() |
A. H.M. van Straten, M. A. Soliman Hamad, A. J. van Zundert, E. J. Martens, J. P.A.M. Schonberger, and A. M. de Wolf Preoperative C-reactive protein levels to predict early and late mortalities after coronary artery bypass surgery: Eight years of follow-up J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 954 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. I. Paraskevas Applications of statins in cardiothoracic surgery: more than just lipid-lowering Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 377 - 390. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |